Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial

MLA

Peterson, Benjamin E., et al. Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280631298&authtype=sso&custid=ns315887.

APA

Peterson, B. E., Bhatt, D. L., Steg, P. G., Oldgren, J., Maeng, M., Zeymer, U., Halvorsen, S., Hohnloser, S. H., Lip, G. Y. H., Kimura, T., Nordaby, M., Miede, C., Kleine, E., Ten Berg, J. M., & Cannon, C. P. (2021). Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.

Chicago

Peterson, Benjamin E., Deepak L. Bhatt, Ph Gabriel Steg, Jonas Oldgren, Michael Maeng, Uwe Zeymer, Sigrun Halvorsen, et al. 2021. “Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280631298&authtype=sso&custid=ns315887.